I was asked by senior reporter for The Defender, Michael Nevradakis, Ph.D., to comment on Pfizer’s delay of their myocarditis study in kids and young adults to 2030.
My published comments can be read …
Continue reading this post for free, courtesy of Sonia Elijah.